Lakefront Biotherapeutics NV (GXE.XETRA) Q2 2026 Earnings

May 6Confirmed
Q3 2025
Q4 2025
Q2 2026
-3.13
-2.02
-0.91
0.21

Details

Expected EPS
-0.80138023758259
Actual EPS
0.2064761727
Surprise EPS
1.01
Surprise Percent
+125.77%

Description

⁨Lakefront Biotherapeutics NV⁩ (⁦GXE.XETRA⁩) has reported earnings of ⁦0.2064761727⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts